Target intelligence / Profile preview

5-Fluorouracil (5-FU) resistance pathways (5-FU resistance)

Target
5-FU resistance
Molecular classification
Enzyme, Transporter, Transcription factor, Other
01

Overview

5-Fluorouracil (5-FU) resistance pathways represent the multifaceted biological mechanisms that cancer cells utilize to evade the cytotoxic effects of 5-FU, a widely used antimetabolite (Longley et al., 2003 [1]). The primary mechanism involves the upregulation of thymidylate synthase (TYMS), the enzyme 5-FU is designed to inhibit, thereby maintaining dTMP production for DNA synthesis (Peters et al., 2002 [2]). Additionally, high levels of dihydropyrimidine dehydrogenase (DPYD) can lead to rapid catabolism of the drug, reducing its bioavailability and therapeutic impact (Diasio and Johnson, 1999 [3]). Resistance is also linked to deficiencies in activating enzymes such as orotate phosphoribosyltransferase (OPRT) and thymidine phosphorylase (TYMP), which are necessary to convert 5-FU into its active metabolites (Ichikawa et al., 2003 [4]). Furthermore, alterations in apoptotic signaling, such as p53 mutations or overexpression of anti-apoptotic proteins like Bcl-2, allow cells to survive 5-FU-induced DNA damage (Zhang et al., 2008 [5]). Changes in drug transport, specifically the overexpression of multidrug resistance-associated proteins (MRPs), can further decrease intracellular drug concentration (Longley et al., 2003 [1]). Understanding these pathways is vital for developing combination therapies and personalized treatment strategies to overcome chemoresistance in various malignancies, particularly colorectal cancer. References: [1] Longley DB, et al. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330-8. [2] Peters GJ, et al. Thymidylate synthase and drug resistance. Eur J Cancer. 2002;38(6):758-66. [3] Diasio RB, Johnson MR. Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance. Clin Cancer Res. 1999;5(10):2672-3. [4] Ichikawa W, et al. Both gene expression of thymidylate synthase and orotate phosphoribosyltransferase predict response to 5-fluorouracil. Clin Cancer Res. 2003;9(11):4059-64. [5] Zhang N, et al. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules. 2008;13(8):1551-69.

Other names
5-FU chemoresistanceFluorouracil resistance mechanismsResistance to 5-fluorouracil
02

Mechanism of action

Inhibition of thymidylate synthase and incorporation of fluoronucleotides into RNA and DNA, leading to cell cycle arrest and apoptosis; resistance mechanisms counteract these effects through enzyme upregulation or altered metabolism (Longley et al., 2003 [1]).

03

Biological functions

DNA synthesisPyrimidine metabolismApoptosisDrug metabolismCell cycle
04

Disease associations

Cancer
05

Safety considerations

Severe toxicity in DPD-deficient patientsMyelosuppressionGastrointestinal toxicityHand-foot syndrome
06

Interacting drugs

5-Fluorouracil

5 more in the full profile.

07

Biomarkers

Thymidylate synthase (TYMS) expressionDihydropyrimidine dehydrogenase (DPYD) activityThymidine phosphorylase (TYMP) expressionMicrosatellite instability (MSI) status

Beyond the preview

Go deeper on 5-Fluorouracil (5-FU) resistance pathways (5-FU resistance).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-Fluorouracil (5-FU) resistance pathways (5-FU resistance).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call